Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Rang in Aktien #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Aktienkurs
$0.1502
Zuletzt synchronisiert: 2024-11-04
Marktkapitalisierung
$6.43M
Veränderung (1 Tag)
-5.45%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Renalytix Plc (RNLX)

Kategorie

EPS für Renalytix Plc (RNLX)
EPS zum September 2024 TTM: $-0.52
Laut den aktuellen Finanzberichten und dem Aktienkurs von Renalytix Plc beträgt das aktuelle EPS des Unternehmens (TTM) $-0.52. Am Ende des Jahres 2023 betrug das EPS $-1.10 ein Rückgang im Vergleich zu dem EPS von 2022, das $-1.24 betrug.
EPS-Verlauf von Renalytix Plc von 2018 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US